Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology

Author:

Snaterse M.ORCID,Deckers J.W.,Lenzen M.J.,Jorstad H.T.,De Bacquer D.,Peters R.J.G.,Jennings C.,Kotseva K.,Scholte op Reimer W.J.M.

Funder

Amgen

AstraZeneca

Bristol-Myers Squibb

GlaxoSmithKline

F Hoffman-la Roch, Merck

Sharp& Dohme

Netherlands Organisation for Scientific Research

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. The Leading Causes of Death in the World, 2000 and 2012;WHO World Health Organisation,2014

2. Smoking cessation for the secondary prevention of coronary heart disease;Critchley;Cochrane Database Syst. Rev.,2004

3. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries;Kotseva;Eur. J. Prev. Cardiol.,2016

4. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries;Kotseva;Eur J Cardiovasc Prev Rehabil,2009

5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3